Two Sigma Advisers’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,315
| Closed | -$55K | – | 2795 |
|
|
2022
Q2 | $55K | Sell |
1,315
-4,200
| -76% | -$176K | ﹤0.01% | 2466 |
|
|
2022
Q1 | $374K | Sell |
5,515
-10
| -0.2% | -$678 | ﹤0.01% | 2126 |
|
|
2021
Q4 | $671K | Sell |
5,525
-1,505
| -21% | -$183K | ﹤0.01% | 1764 |
|
|
2021
Q3 | $990K | Buy |
7,030
+1,005
| +17% | +$142K | ﹤0.01% | 1627 |
|
|
2021
Q2 | $1.66M | Buy |
6,025
+2,715
| +82% | +$746K | ﹤0.01% | 1391 |
|
|
2021
Q1 | $708K | Buy |
+3,310
| New | +$708K | ﹤0.01% | 1842 |
|